These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 20617377

  • 1. Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families.
    Kang P, Mariapun S, Phuah SY, Lim LS, Liu J, Yoon SY, Thong MK, Mohd Taib NA, Yip CH, Teo SH.
    Breast Cancer Res Treat; 2010 Nov; 124(2):579-84. PubMed ID: 20617377
    [Abstract] [Full Text] [Related]

  • 2. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
    Stadler ZK, Saloustros E, Hansen NA, Schluger AE, Kauff ND, Offit K, Robson ME.
    Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693
    [Abstract] [Full Text] [Related]

  • 3. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
    Ticha I, Kleibl Z, Stribrna J, Kotlas J, Zimovjanova M, Mateju M, Zikan M, Pohlreich P.
    Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
    [Abstract] [Full Text] [Related]

  • 4. Genomic large rearrangement screening of BRCA1 and BRCA2 genes in high-risk Turkish breast/ovarian cancer patients by using multiplex ligation-dependent probe amplification assay.
    Manguoğlu E, Güran S, Yamaç D, Simşek M, Akdeniz S, Colak T, Gülkesen H, Lüleci G.
    Cancer Invest; 2011 Jan; 29(1):73-7. PubMed ID: 20919953
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.
    Riahi A, Chabouni-Bouhamed H, Kharrat M.
    Cancer Genet; 2017 Jan; 210():22-27. PubMed ID: 28212807
    [Abstract] [Full Text] [Related]

  • 6. Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families.
    Rudnicka H, Debniak T, Cybulski C, Huzarski T, Gronwald J, Lubinski J, Gorski B.
    Mol Biol Rep; 2013 Dec; 40(12):6619-23. PubMed ID: 24065545
    [Abstract] [Full Text] [Related]

  • 7. Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series.
    McVeigh TP, Cody N, Carroll C, Duff M, Farrell M, Bradley L, Gallagher D, McDevitt T, Green AJ.
    Cancer Genet; 2017 Aug; 214-215():1-8. PubMed ID: 28595730
    [Abstract] [Full Text] [Related]

  • 8. Large genomic rearrangements of BRCA1 and BRCA2 among patients referred for genetic analysis in Galicia (NW Spain): delimitation and mechanism of three novel BRCA1 rearrangements.
    Fachal L, Blanco A, Santamariña M, Carracedo A, Vega A.
    PLoS One; 2014 Aug; 9(3):e93306. PubMed ID: 24686251
    [Abstract] [Full Text] [Related]

  • 9. Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population.
    Zhang J, Fackenthal JD, Huo D, Zheng Y, Olopade OI.
    Breast Cancer Res Treat; 2010 Nov; 124(2):573-7. PubMed ID: 20596889
    [Abstract] [Full Text] [Related]

  • 10. Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer.
    Lim YK, Lau PT, Ali AB, Lee SC, Wong JE, Putti TC, Sng JH.
    Clin Genet; 2007 Apr; 71(4):331-42. PubMed ID: 17470134
    [Abstract] [Full Text] [Related]

  • 11. Identification of large genomic rearrangement of BRCA1/2 in high risk patients in Korea.
    Kim DH, Chae H, Jo I, Yoo J, Lee H, Jang W, Park J, Lee GD, Jeon DS, Lee KH, Hur SY, Chae BJ, Song BJ, Kim M, Kim Y.
    BMC Med Genet; 2017 Mar 28; 18(1):38. PubMed ID: 28351343
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.
    Pylkäs K, Erkko H, Nikkilä J, Sólyom S, Winqvist R.
    BMC Cancer; 2008 May 26; 8():146. PubMed ID: 18501021
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A multi-institutional study of the prevalence of BRCA1 and BRCA2 large genomic rearrangements in familial breast cancer patients.
    Seong MW, Cho SI, Kim KH, Chung IY, Kang E, Lee JW, Park SK, Lee MH, Choi DH, Yom CK, Noh WC, Chang MC, Park SS, Kim SW, Korean Hereditary Breast Cancer Study Group.
    BMC Cancer; 2014 Sep 01; 14():645. PubMed ID: 25176351
    [Abstract] [Full Text] [Related]

  • 17. The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer.
    van der Merwe NC, Oosthuizen J, Theron M, Chong G, Foulkes WD.
    BMC Cancer; 2020 May 06; 20(1):391. PubMed ID: 32375709
    [Abstract] [Full Text] [Related]

  • 18. Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea.
    Cho JY, Cho DY, Ahn SH, Choi SY, Shin I, Park HG, Lee JW, Kim HJ, Yu JH, Ko BS, Ku BK, Son BH.
    Fam Cancer; 2014 Jun 06; 13(2):205-11. PubMed ID: 24566764
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families.
    Buffone A, Capalbo C, Ricevuto E, Sidoni T, Ottini L, Falchetti M, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G.
    Breast Cancer Res Treat; 2007 Dec 06; 106(2):289-96. PubMed ID: 17333342
    [Abstract] [Full Text] [Related]

  • 20. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
    Ratajska M, Brozek I, Senkus-Konefka E, Jassem J, Stepnowska M, Palomba G, Pisano M, Casula M, Palmieri G, Borg A, Limon J.
    Oncol Rep; 2008 Jan 06; 19(1):263-8. PubMed ID: 18097605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.